Summary. The effects of synthetic platelet-activating factor (PAF-acether) and mouse embryo-conditioned medium (a source of embryo-derived PAF (EPAF)) on production of early pregnancy factor (EPF) were compared. Embryo-conditioned medium, itself inactive in the EPF bioassay, stimulated ovarian production of EPF in vitro but PAF-acether did not. In vivo, embryo-conditioned medium induced EPF activity in serum of oestrous female, but not in male, mice in contrast to PAF-acether, which induced activity in serum of both male and female mice. This PAF-induced activity was transitory, declining significantly by 2 h and disappearing by 3 h after injection. Activity induced by embryo-conditioned medium was first evident at 2 h after injection, serum concentrations increasing up to 6 h after injection. By discriminating between the behaviour of PAF-acether and EPAF, these studies reinforce the conclusions of other workers that the molecule produced by the embryo is not PAF. Further investigations into the mechanism of action of PAF-acether revealed that it is a potent inducer of activity in the EPF bioassay, with an absolute requirement for platelets in the spleen cell suspension used in the assay. This platelet-derived active species was bound specifically by an anti-EPF monoclonal antibody, indicating that it is EPF-like. This is consistent with parallel studies showing that platelets are not required for induction of activity by either pregnancy serum or purified EPF. These studies were applied to the PAF-induced leukotriene-like species, which had been found by others to be active in the EPF bioassay. Pregnancy serum induced the appearance of this substance from the spleen cell suspension used in the assay; thus the leukotriene-like substance may be regarded as an effector molecule in vitro or mediator of the initiating stimulus of EPF in the bioassay.
Introduction
Maternal recognition of pregnancy is classically regarded as first occurring in the peri-implantation period, but communications commencing at virtually the time of fertilization have been identified. These include early pregnancy factor (EPF), produced by the maternal ovary within 6 h of fertiliz¬ ation in response to an embryonic signal, termed ovum factor (Morton et ai, 1980 (Morton et ai, , 1987 Cavanagh et ai, 1982 Cavanagh et ai, , 1991 , and embryo-derived, platelet-activating factor (EPAF), detectable within 10 h of mating by its induction of mild maternal thrombocytopaenia (O'Neill, 1985a, b) . It has been suggested that ovum factor and EPAF have similar properties and thus that these two early events in mammalian pregnancy may be linked (O'Neill, 1985c) . Studies by Orozco et ai (1986) showing that EPF production was stimulated in nonpregnant female, but not in male, mice within 1 h of injection with synthetic platelet-activating factor (PAF-acether) and by Sueoka et ai (1988) demonstrating stimulation of EPF production by PAF-acether in vivo and in vitro support the proposition. Orozco et al. (1990) and Clarke et ai (1990) (1989) failed to demonstrate PAF activity in medium conditioned by human embryos using the washed rabbit-platelet-aggregation bioassay; Smal et ai (1990) , using the same bioassay, also failed to detect PAF activity in mouse embryo-conditioned medium. Smal et ai were unable to detect PAF in medium conditioned by mouse embryos using a highly specific and sensitive radioimmunoassay capable of detecting^1 pg PAF/embryo. They concluded that embryos do not produce significant quantities of PAF or of one of the biologically active analogues of PAF. Thus, experimental results obtained with PAF-acether substituting for EPAF must be seriously questioned.
These conclusions, with our recent studies on mechanisms involved in the bioassay for EPF, the rosette inhibition test (Rolfe et ai, 1988 (Rolfe et ai, , 1989 Cavanagh et ai, 1991) , prompted a re-examination of experiments suggesting that EPAF and EPF are linked. The effects of PAF-acether and mouse embryo-conditioned medium (a source of both EPAF and ovum factor) on EPF production, in vivo and in vitro, were therefore compared in this study.
Materials and Methods

Mice
Male and virgin female BALB/c, C57BL/6 and Quackenbush mice, [6] [7] [8] (Rugh, 1968 (Edwards & Gates, 1959 ).
Embryo-conditioned medium
Oviducts were excised from Quackenbush mice on Day 2 of pregnancy and embryos flushed and washed with Dulbecco's modified Eagle's medium (DMEM; Flow Laboratories, Irvine, UK) containing 1 mg bovine serum albumin (BSA: Sigma Chemical Co., St Louis, MO, USA), 100 U penicillin (CSL: Melbourne, Australia) and 100 mg streptomycin (Sigma)/ml. Groups often 2-cell embryos were placed in 0-2 ml of the culture medium in 96-well micro¬ titre plates (Nunclon, Nunc, Denmark) and incubated at 37°C for 24 h in 5% C02 in air. Embryos were then removed and conditioned medium was stored under sterile conditions at 4°C and used within 2-3 days. mEPF EPF was purified from medium conditioned by oestrous mouse ovaries and from oviducts stimulated with prolactin and medium conditioned by mouse embryos, as described by Cavanagh (1984) .
PAF-acether
A stock solution of 1 mg PAF-acether (l-0-hexadecyl-2-0-acetyl-sn-glycero-3-phosphocholine; Sigma)/ml in absolute ethanol was prepared and stored at -30°C. For in-vivo experiments, this solution was diluted in 0-9% (w/v) sodium chloride containing 001% (w/v) BSA; for in-vitro experiments, it was diluted in Hank's balanced salt sol¬ ution, without calcium or magnesium containing 001% (w/v) BSA (HBSS and BSA).
Preparation of supernatants SI and S2 Following the terminology and methods of Orozco et ai (1990) , these supernatants were prepared by incubation of 1-5 Cells were then pelleted, supernatant SI was removed and the cells were washed twice with HBSS. They were then resuspended in 0-2 ml HBSS, incubated for a further 0-5 h at 37°C and pelleted and supernatant S2 was removed.
Bioassay for EPAF
The assay was performed according to the method of O'Neill (1985b (Morton et ai, 1974 (Morton et ai, , 1976 .
The assay was performed with spleen cells from male mice, rabbit antimouse lymphocyte serum and human red blood cells (Rolfe et ai, 1984; Morton et (Rolfe et ai, 1988) .
Relationship between embryo-conditioned medium, PAF-acether and EPF Ovarian stimulation in vitro. These studies followed the methods described by Cavanagh et ai ( 1982, 1991 ). Ovaries were removed from superovulated Quackenbush mice, washed extensively with DMEM and incubated in DMEM overnight to remove entrapped blood. After further washing, a single ovary was incubated for 24 h at 37°C in 0-2 ml embryo-conditioned medium, with and without prolactin (100 ng rat prolactin, PRL-6, NIH, Bethesda, USA; Cavanagh et ai, 1982) . Parallel cultures were prepared with 0-2 ml PAF-acether (100 pg/ml in DMEM) or DMEM alone substituting for embryo-conditioned medium. Supernatants were dialysed overnight against HBSS to remove substances used for stimulation and then tested in the rosette inhibition test in 10-fold dilutions from 10"' to 10"6.
The studies were performed in triplicate.
Activity in vivo. Male and oestrous female BALB/c mice were injected i.p. with either 1 ng PAF-acether or 0-25 ml embryo-conditioned medium, shown to have activity in the bioassay for EPAF. Control groups were injected i.p. with either 01 ml 0-9% NaCl and 001% BSA or 0-25 ml culture medium alone. Blood was sampled from groups of 3 under halothane anaesthesia by cardiac puncture or from the periorbital plexus 1, 2, 4 and 6 h after injection. Serum was inactivated at 56°C for 0-5 h and stored at -30°C prior to testing in the rosette inhibition test, diluted 1 in 4 and in 10-fold dilutions from 10"1 to 10"8.
Activity in the rosette inhibition test. Embryo-conditioned medium and PAF-acether (1 µg/ml), with and without 10% oestrous mouse serum, were tested in the rosette inhibition test at dilutions from 1 in 4 to 10~12, as was the supernatant SI induced from spleen cells by 5 nmol PAF/1. Studies were performed in duplicate.
Mechanism of action of PAF-acether in the EPF bioassay Cell preparation. Spleen cell suspensions (2 IO7 cells/ml in HBSS) were prepared as described by Rolfe et ai (1984) . Platelet depletion was carried out by centrifugation at 200 g for 15 min on a 20% (w/v) sucrose gradient. The pellet containing lymphoid cells was resuspended and subjected to a second gradient separation. The resulting preparation was examined by phase-contrast microscopy to determine the efficacy of the procedure.
Platelets were prepared from spleen cell suspensions by centrifugation at 200 # for 15 min followed by recentrifugation of the supernatant at 900 g for 15 min; for platelet preparation, spleen cell suspensions were not subjected to red cell lysis.
Preparation ofsupernatants. PAF-acether (0-4 ml, 100 pg/ml, in HBSS and BSA) was incubated at 37°C for (1990) to the supernatant S2, induced from spleen cells by 5 nmol PAF/1, but substituted Day-10 mouse pregnancy serum (10"3 in PBS and BSA) for PAF.
Siliconized glassware was used throughout. A 0-5 ml aliquant of diluted serum was extracted with isopropanol, formic acid (5 mol/1) and ether (0-5:0-03:1 -5). The aqueous and organic phases were then separated and~50 µ at the inter¬ face was discarded; the aqueous phase (~0 -5 ml) was adjusted to pH 70. After addition of 0015 volumes of NH4OH (10 mol/1), the organic phase was evaporated with a stream of N2, the tube rinsed twice with PBS and the residue dissolved in 0-5 ml methanol and chloroform (1:1). This was resolved into polar and nonpolar phases by addition of 0-22 ml NH4OH ( 10 mmol/1). The phases were separated and again 50 µ at the interface was discarded. Methanol was evaporated from the polar phase with a stream of N2 and the remaining aqueous mixture made up to 0-5 ml with PBS and BSA. The nonpolar phase was evaporated with a stream of N2 and the residue dissolved in 50 µ 65% methanol and 01% acetic acid at pH 5-6. The first aqueous, second aqueous and second organic phases were then tested in the rosette inhibition test in 10-fold dilutions.
The experiment was repeated with 0-5 ml supernatant S2 induced from spleen cells by Day-10 mouse pregnancy serum (10~3 in HBSS and BSA). Both studies were performed in duplicate.
Results
In-vitro production of EPAF by 2-cell embryos Culture medium alone did not affect the number of platelets when injected into splenectomized mice. Medium conditioned by 2-cell embryos induced a 37% reduction in number of platelets; the reduction observed after injection of PAF-acether was 23%.
Relationship between embryo-conditioned medium, PAF-acether and EPF Ovarian stimulation in vitro. EPF activity was detected in supernatants from ovaries incubated with embryo-conditioned medium in the presence of 100 ng/0-2 ml prolactin (limiting dose 10"5),
but not in supernatants from ovaries incubated with PAF-acether, either in the presence or absence of prolactin or with the negative control medium. Activity in vivo. Serum from male and female mice was active in the rosette inhibition test at 1 h after injection with PAF-acether (Fig. 1) . The difference in limiting dose of male (10~5-10~6) and female (10~3) sera is consistent with the presence of an oestrous-dependent inhibitor (Cavanagh et ai, 1991) , which substantially reduces the response of EPF in the rosette inhibition test. The differ¬ ence probably explains also the failure of Orozco et ai (1986) to detect activity in male sera after injection with PAF; dilutions beyond those observed to be positive with female sera were not tested. This PAF-induced activity was transitory (Fig. 2) . By 2 h after injection, the limiting dose of male and female sera was declining and, by 4 the region of response shifted to 002-0-5 fmol/1, an activity threshold 4 times lower than the lowest dilution tested by Orozco et ai (1986, 1990 As would be expected from these results, the supernatant SI, induced from spleen cells by 5 nmol PAF-acether/1, and studied extensively by Orozco et ai (1990) in an attempt to explain its apparent activity only in the presence of oestrous serum, was active in the presence and absence of oestrous serum (Fig. 4) Fig. 3, should (Table  2) by immunoabsorption experiments with an anti-EPF monoclonal antibody. The activity of PAF-induced platelet supernatant, desalted to remove PAF, was removed by immobilized mono¬ clonal anti-EPF IgM (but not by control gels) and recovered almost quantitatively by treatment with buffer at pH 2-4, indicating specific recognition of the active species by this antibody.
Extraction of pregnancy serum and pregnancy-serum-induced S2 factors. To reconcile these results with the studies of Clarke et ai (1990) , which characterized the PAF-induced active S2 factors as leukotriene-like, the same lipid extraction technique was applied to the archetypal source of EPF, pregnancy serum, and to pregnancy-serum-induced S2 factors. The activity of pregnancy serum was extracted into the first aqueous phase, where proteins partition (Fig. 5a) ; activity was not found in the lipid fraction and removal of lipid appeared to enhance activity of the aqueous fraction significantly. This contrasts with activity displayed by pregnancy-serum-induced S2 factors (Fig. 5b) . While activity was still observed in the first aqueous (protein) phase, (indicating the 
Discussion
Some aspects of the relationship between PAF, embryo-conditioned medium and EPF have been clarified by these studies. As in previous investigations, (Morton et ai, 1980 (Morton et ai, , 1987 Cavanagh et ai, 1982 Cavanagh et ai, , 1991 (1986, 1990) could be reversed by oestrous serum. As the results in Fig. 4 show, such an explanation is unnecess¬ ary; PAF is simply inducing activity in the rosette inhibition test which is susceptible to the action of an oestrous-dependent inhibitor (Cavanagh et ai, 1991) . However, this inhibitor acts on the initiating signal in the assay rather than on substances induced by it; inhibitory effects are observed, therefore, at the SI rather than at the S2 stage, as seen by Orozco et ai (1990) . Notwithstanding these misapprehensions, the studies by Clarke's group, on the action of PAF in the EPF bioassay, reveal interesting possibilities. This is best appreciated by considering the rosette inhibition test according to our current understanding, using these authors' terminology. The cell pellet PI, produced by incubation of spleen cells with pregnancy serum or its active consti¬ tuent EPF, after washing to remove the inducing stimulus, provides the ALS-enhancing effect measured by the bioassay (Morton et ai, 1976) . Rolfe et al. (1988 Rolfe et al. ( , 1989 (1990) suggest that leukotrienes might be among these latter factors, consistent with the implication of these lipids in suppressor cell circuits (Parker, 1987 (Morton, 1984) , and the leukotriene-like species, detected to date in vitro, are important elements in this process is the critical question which further studies must address.
There are two important consequences of these investigations with platelets. The (Whal et ai, 1989) . EPF displays both growth regulatory (Quinn et ai, 1990 ) and immunomodulatory properties (Noonan et ai, 1979; Rolfe et ai, 1983 Rolfe et ai, , 1988 
